17/04/2020 - Campus Can Ruti, Innovation, Research

100 RESPIRA ventilators from GAPInnova delivered to the SEM to continue clinical trials with COVID-19 patients in other hospitals

The emergency ventilator RESPIRA, developed by GPAINNOVA, with the support of the Hospital Clínic, Barcelona, the Germans Trias i Pujol Research Institute and the University of Barcelona have passed the first stage of the clinical trial with the first two patients affected by COVID-19 successfully. With the first phase complete, the study can be expanded to other hospitals in the region. Thanks to the support received from the public, companies and administrations today the first 100 emergency ventilators c have been delivered to the SEM for distribution.

08/04/2020 - Campus Can Ruti, Innovation, Research

The autonomous ventilation device (DAR) developed by the Hospital Clínic Barcelona, Germans Trias i Pujol, the University of Barcelona and GASN2 is authorized by the AEMPS to start clinical trials

The Spanish Agency of Medicines and Medical Devices (AEMPS) has today given the green light to test the device developed by the company GasN2 with the support of professionals from the Hospital Clínic Barcelona, the Germans Trias i Pujol Research Institute (IGTP) and the University of Barcelona (UB). The prototype uses a system of electro pneumatic valves to supply and control the volume of oxygen necessary for each patient. Support from civil society, companies and administrations has been key to the development of the design and industrial scaling up of the model to contribute to the provision of the ventilators needed by the health system.

06/04/2020 - Campus Can Ruti, Innovation, Research

Respira, the new ventilator device developed gets the go ahead from the AEMPS for clinical trials

The Spanish Agency of Medicines and Medical Devices (AEMPS) has approved a clinical trial with the ventilation device RESPIRA developed by GAPInnova with the support of professionals from the Hospital Clínic Barcelona, the Germans Trias I Pujol Research Institute and the University of Barcelona. This is the second device developed with the support of these organizations to be approved by the AEMPS for testing on patients at the Hospital Clinic Barcelona and at Can Ruti. The prototype of the RESPIRA device mechanizes manual ressusitations with AMBU devices providing automatic respiration assistance and monitoring.

03/04/2020 - Innovation, Institutional

New ventilator device developed by the Hospital Clínic, Germans Trias i Pujol and Barcelona University with Protofy.xyz gets the go ahead from the AEMPS for clinical trials

The Spanish Agency of Medicines and Medical Devices (AEMPS) approves a clinical trial with the emergency ventilator device developed by the Barcelona company Protofy.xyz with the financial and scientific support of professionals from the Hospital Clínic Barcelona, the Germans Trias i Pujol hospital and the University of Barcelona. It is a device to automate manual ventilation processes and provide respiratory support for patients in emergency situations when conventional ventilators are unavailable. The support received from civil society, companies and administrations has been key in developing the design and industrial scaling of this model, which will contribute to providing the health system with the necessary ventilators.

30/03/2020 - Innovation, Institutional

Can Ruti Campus, Hospital Clínic Barcelona and Barcelona University collaborate in a Ministry of Health project to develop emergency ventilators

The Germans Trias i Pujol and Clínic Barcelona Hospitals and the University of Barcelona are providing scientific support to develop a device that allows patients to be ventilated in the absence of conventional ventilators. Three Catalan companies (Protofy.xyz, GasN2 and Innova) are creating and adapting emergency models of ventilators to deal with the crisis caused by COVID-19. The three proposals are now in the simulation and experimental phases. When they have completed all the validations and have obtained the authorization of the Spanish Agency of Medicines and Medical Devices (AEMPS) production will start on industrial scale. Support from civil society will be key in developing the three models and financing production to contribute to providing the Catalan health system with the ventilators needed.

19/03/2020 - Innovation, Research

A gene therapy project at the IGTP is one of the four biomedical initiatives chosen by the CaixaImpulse Consolidate Programme

The gene therapy project at the IGTP to treat Friedreich's ataxia, a rare disease, led by the research group for Neurogenetics at the IGTP, is one of the four selected in the first call for CaixaImpulse 2019. It is the first edition of the programme run by 'la Caixa' to promote innovation projects in their later stages. 

15/10/2019 - Campus Can Ruti, Innovation, Research

The Comparative Medicine and Bioimaging Centre (CMCiB) opens its new facilities for research with bioimage

The Director of the Germans Trias i Pujol Research Institute (IGTP), Manel Puig, and the President of the Canon Medical Systems Corporation (Canon Medical), Toshio Takiguchi, visited the CMCiB on Monday 14 October to view the new bioimaging facilities that complete the center as a pioneering research platform in comparative medicine. The CMCiB, a center promoted by the IGTP and a benchmark in comparative medicine, bioimaging and computational models, is a pioneer in the application of alternative methods of biomedical research that directly affect the improvement of people's health.

20/06/2019 - Campus Can Ruti, Innovation, Institutional, Research

In a brand new format, scientists come together to share and discuss research on the Can Ruti Campus in the First IGTP PI Retreat

Principal investigators from the nine areas of research on the Can Ruti Campus met together to discuss topics of concern in the current research environment. During the day, researchers enjoyed inputs from the IGTP research community and external speakers and were able to take advantage of the many moments available for networking and sharing.

07/06/2019 - Innovation, Institutional, Research

Manremyc opens a funding round of 250,000 euros through the Capital Cell platform

Manremyc, a spin-off of the IGTP specialised in the development of a probiotic against tuberculosis, has opened a funding round through Capital Cell, the first on-line investment platform in Europe specialized in biomedicine. The objective of the campaign is to reach 250,000 euros, with a minimum investment requirement per person of only 600 euros. Up to now, the company has secured 35% of the investment, which includes participation from the Reig family, main shareholders in the pharmaceutical company Reig Jofre.

10/05/2019 - Innovation, Research

Aniling is among the projects selected for this year’s CRAASH Barcelona Programme

Ten international projects have been selected for the second edition of CRAASH Barcelona and Aniling is one of them.  CRAASH is the business acceleration programme organized by Biocat and CIMIT (Boston). Aniling is a spin-off company of the IGTP, which has developed a method for analysing the genome and epigenome of a patient simultaneously, an advance in personalized medicine for both research and clinical settings.